Health Benefits of Curcumin in the Prevention and Treatment of Diseases
Main Article Content
Abstract
Medicines obtained from plants have portrayed the crucial involvement in both cultures’ health, ancient and modern times because of their inexpensive properties and belief of the people that natural products have less or no side effects. Curcuma longa (turmeric), a perennial shrub integrated from the family Zingiberaceae, was used for a long as a spice to alleviate inflammation, discomfort, healing of wounds, and digestive ailments in Asian food. In various forms, curcumin is recognized and utilized globally for many health advantages, mainly due to its antioxidant and anti-inflammatory actions. The therapeutic effectiveness of curcumin against many illnesses, including arthritis, cardiovascular, diabetes, neurological, Crohn's disease, and tumor have already been recorded. The therapy of curcumin has been validated in a variety of respiratory diseases, such as asthma, bronchial hyperactivity, and allergy, as well as for liver, anorexia, rheumatism, and diabetic wounds according to Ayurvedic medicine. It is used to treat abdominal pain-related disorders as in traditional Chinese Medicine. It was utilized as a treatment for sprains and swelling in ancient Hindu medicine. This review paper outlines many health advantages and activities of Curcumin.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Harvey AL. Natural Products in Drug Discovery. Drug Discovery Today 2008; 13(19-20): 894-901.
II. Calixto JB. The role of natural products in modern drug discovery. An Acad Bras Cienc 2019; 91(3): e20190105.
III. Goel A, Kunnumakkara AB, Aggarwal BB. Curcumin as “Curecumin”; from kitchen to clinic. Biochemical pharmacology 2008; 75: 787-809.
IV. Dias DA, Urban S, Roessner U. A Historical Overview of Natural Products in Drug Discovery. Metabolites 2012; 2: 303-336.
V. Newman DJ, Cragg GM, Snader KM. Natural Products as Source of New Drugs over the Period 1981-2002. Journal of Natural Products 2003; 66: 1022-1037.
VI. Clark AM. Natural Products as a Resource for New Drugs. Pharmaceutical Research 1996; 13(8): 1133-1141.
VII. Newman DJ, Cragg GM, Snader KM. the influence of natural products upon drug discovery. Natural Products Reports 2000; 17: 215-234.
VIII. Cheuka PM, Mayoka G, Mutai P, Chibale K. The Role of Natural Products in Drug Discovery and Development against Neglected Tropical diseases. Molecules 2017; 22(1): 58.
IX. Sharma RA, Gescher AJ, Steward WP. Curcumin: the story so far. European Journal of Cancer 2005; 41: 1955-1968.
X. Tonnesen HH, Karlsen J. studies on Curcumin and Curminoids. Z Lebensm Unters Forsch 1985; 180: 402-404.
XI. Kiuchi F, Goto Y, Sugimoto N, Akao N, Kondo K, Tsuda Y. Nematocidal activity of Turmeric: synergistic action of Curcuminoids. Chemical and Pharmaceutical Bulletin 1993; 41(9): 1640-1643.
XII. Anand P, Kunnumakkarra AB, Newman RA, Aggarwal BB. Bioavailability of Curcumin: Problems and Promises. Molecular Pharmaceutics 2007; 4(6): 807-818.
XIII. Moran MP, Fernandez JM, Tortosa CR, Tortose MR. Curcumin and Health. Molecules 2016; 21: 264.
XIV. Aggarwal BB, Sundaram C, Malani N, Ichikawa H. Curcumin: The Indian Solid Gold. Advances in Experimental Medicine and Biological Sciences 2007;595:1-75.
XV. Araujo CAC, Leon LL. Biological Activities of Curcuma Longa L. Memórias do Instituto Oswaldo Cruz 2001; 96(5): 723-728.
XVI. Jagetia GC, Aggarwal BB. “Spicing Up” of the Immune System by Curcumin. Journal of Clinical Immunology 2007; 27(1):19-35.
XVII. Shishodia S, SethiS, Aggarwal BB. Curcumin: Getting Back to the Roots. Annals of the New York Academy of Sciences 2005; 1056:206-217.
XVIII. Sethi G, Sung B, Aggarwal BB. Nuclear Factor-KB Activation: From Bench to Bedside.Experimental Biology and Medicine 2008; 233:21.
XIX. Anthwal A, Thakur BK, Rawat MSM, Rawat DS, Tyagi AK, Aggarwal BB. Synthesis, Characterization and In Vitro AnticancerActivity of C-5 Curcumin Analogues with Potential to Inhibit TNF-????-Induced NF-????B Activation. BioMed Research International 2014; 2014:524161.
XX. Han S, Yang Y. Antimicrobial activity of wool fabric treated with curcumin. Dyes and Pigments 2005; 64: 157-161.
XXI. Moghadamtousi SZ, Kadir HA, Hassandarvish P, Tajik H, Abubakar S, Zandi K. A Review on Antibacterial, Antiviral, and Antifungal Activity of Curcumin. BioMed Research International 2014; 2014:186864.
XXII. Mohit, Hussain MS, Mohapatra C, et al. Long-Acting Reversible Contraceptives - IUDs/IUS and Implants: A Review. International Journal of Pharmaceutical Sciences Review and Research 2021; 68:135-142.
XXIII. Rai D, Singh JK, Roy N, Panda D. Curcumin inhibits FtsZ assembly: an attractive mechanism for its antibacterial activity. Biochemical Journal 2008; 410: 147-156.
XXIV. De R, Kundu P, Swarnakar S, Ramamurthy T, Chowdhury A, Nair GB et al. Antimicrobial Activity of Curcumin against Helicobacter pyloriIsolatesfrom India and during Infections in Mice. Antimicrobial Agents and Chemotherapy 2009; 53(4): 1592-1597.
XXV. Gera M, Sharma N, Ghosh M, Huynh DL, Lee SJ, Min T et al. Nanoformulations of curcumin; an emerging paradigm for improved remedial application. Oncotarget2017; 8(39): 66680-66698.
XXVI. Zandi K, Ramedani E, Mohammadi K, Tajbakhsh S, Deilami I, Rastian Z et al.Evaluation of Antiviral Activities of Curcumin Derivatives against HSV-1 in Vero Cell Line. Natural Product Communication 2010; 5(12): 1935-1938.
XXVII. Hatcher H, Planalp R, Cho J, Torti FM, Torti SV. Curcumin: From ancient medicine to current clinical trials. Cellular and Molecular Life Sciences 2008; 65: 1631-1652.
XXVIII. Kuo ML, Huang TS, Lin JK. Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells. Biochimica et Biophysica Acta 1996; 1317: 95-100.
XXIX. Maheshwari RK, Singh AK, Gaddipati J, Srimal RC. Multiple biological activities of curcumin: A short review. Life Sciences 2006; 78: 2081-2087.
XXX. Giordano A, Tommonaro G. Curcumin and Cancer. Nutrients 2019; 11: 2376.
XXXI. Joe B, Lokesh BR. Role of capsaicin, curcumin and dietary n - 3 fatty acids in loweringthe generation of reactive oxygen species in rat peritoneal macrophages.Biochimica et Biophysica Acta 1994; 1224: 255-263.
XXXII. Pari L, Tewas D, Eckel J. Role of curcumin in health and disease. Informa Healthcare 2008; 114(2): 127-149.
XXXIII. Adams BK, Cai J, Armstrong J, Herold M, Lu YJ, Sun A et al. EF24, a novel synthetic curcumin analog, induces apoptosis in cancer cells via a redox-dependent mechanism. Anti-Cancer Drugs 2005; 16(3): 263-275.
XXXIV. Khopde SM, Priyadarsini I, Venkatesan P, Rao MNA. Free radical scavenging ability and antioxidant efficiency of curcumin and its substituted analogue. Biophysical Chemistry 1999; 80:85-91.
XXXV. Naidu KA, Thippeswamy NB. Inhibition of human low density lipoprotein oxidation by active principles from spices. Molecular and Cellular Biochemistry 2002; 229:19-23.
XXXVI. Chen TH, Yang YC, Wang JC, Wang JJ. Curcumin Treatment Protects Against Renal Ischemia and Reperfusion Injury-Induced Cardiac Dysfunction and Myocardial Injury. Transplantation Proceedings 2013; 45: 3546-3549.
XXXVII. Vollono L, Falconi M, Gaziano R, Lacovelli F, Dika E, Terracciano C et al. Potential of Curcumin in Skin Disorders. Nutrients 2019; 11: 2169.
XXXVIII. Noorafshan A, Esfahani SA. A Review of Therapeutic Effects of Curcumin. Current Pharmaceutical Design 2013; 19:2032-2046.
XXXIX. KocaadamB, Şanlier N. Curcumin, an Active Component of Turmeric (Curcuma Longa), and its Effects on Health. Critical Reviews in Food Science and Nutrition 2017; 57(13):2889-2895.
XL. Hussain MS, Mohit, Pamma P, Kumari B. Treatment modalities of the covid-19 pandemic through repurposed drugs and status of vaccines. International Journal of Applied Pharmaceutics 2021; 13 :48-58.
XLI. Mohit, Hussain MS. Potential role of curcumin as a treatment option for covid-19: a review. Plant Archives 2021; 21(1): 296-305.
XLII. Aggarwal BB, Kumar A, Aggarwal MS, Shishodia S. Curcumin Derived from Turmeric (Curcuma longa):a Spice for All Seasons. Phytopharmaceuticals in Cancer Chemoprevention. 2005.
XLIII. Shehzad A, lee YS. Curcumin: multiple molecular targets mediate multiple pharmacological actions — a review. Drugs of the Future 2010; 35(2): 113-119.
XLIV. Bharti AC, Donato N, Aggarwal BB. Curcumin (Diferuloylmethane) inhibits constitutive and IL-6 inducible STAT3 phosphorylation in human multiple myeloma cells. The journal of immunology 2003; 171: 3863-3871.
XLV. Aggarwal BB, Sung B. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends in Pharmacological Sciences 2008; 30(2): 85-94.
XLVI. Ireson CR, JonesDJ, Orr S, Coughtrie MW, Boocock DJ, Williams ML, Farmer PB, StewardWP, and Gescher AJ. Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol. Biomarkers Prev., 11 (1), 105–111, 2002.
XLVII. Ireson CR, Jones DJL, Orr S, Coughtrie WH, Boocock DJ, Williams ML et al. Metabolism of the Cancer Chemopreventive Agent Curcumin in Human and Rat Intestine. Cancer Epidemiology, Biomarkers & Prevention 2002; 11: 105-111.
XLVIII. Lelli D, Sahebkar A, Johnston TP, Pedone C. Curcumin use in pulmonary diseases: state of the art and future perspectives. Pharmacological Research 2017; 115:133-148.
XLIX. Shoba G, Joseph T, Majeed M, Rajendran R, Srinivas PSSR. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med 1998; 64: 353-356.
L. Bisht S, Feldmann G, Soni S, Ravi R, Karikar C, Maitra A et al. Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy. Journal of Nanobiotechnology 2007; 5: 3.
LI. Steinfeld B, Scott J, Vilander G, Marx L, Quirk M, Lindberg J et al. The Role of Lean Process Improvement in Implementation of Evidence-Based Practices in Behavioral Health Care. Journal of Behavioral Health Services & Research 2014; VOL : 1-14.
LII. Wang W, Zhu R, Xie Q, Li A, Xiao Y, Li K, Liu H. Enhanced bioavailability and efficiency of curcumin for the treatment of asthma by its formulation in solid lipid nanoparticles. International Journal of Nanomedicine 2012; 7: 3667-3677.